藥品名稱
drug name | Influenza virus vaccine 0.5 mL/syringe (Fluarix Tetra) 伏適流【自費】 |
| 藥檔狀態 | 停用 |
成 份
Ingredient | Influenza Virus Vaccine |
| 單位含量 | 0.5 mL/syringe |
| Dosage Forms | 0.5 mL/syringe |
| 顏 色 | |
| Color | |
| 形 狀 | |
| Shape | |
| 劑 型 | 針劑/注射 |
| Dose Form | |
大 小
Size | |
標 示
outward | |
廠商名稱
Manufacturer | 荷商葛蘭素史克藥廠股份有限公司台灣分公司 |
製 造 商
Manufacturer | GLAXOSMITHKLINE BIOLOGICALS BRANCH OF SM |
字 號
Product ID | 衛署菌疫輸字第000939號 |
藥理分類
Pharmacologic Category | Biologic and Immunologic Agents / Immunizations / Vaccines-Virus |
作用機轉
Mechanism of action | Promotes immunity to seasonal influenza virus by inducing specific antibody production. Each year the formulation is standardized according to the US Public Health Service. Preparations from previous seasons must not be used. |
| 用途/適應症 | 自費流感疫苗 |
| Use |
Fluarix Tetra是一種四價流感疫苗，適用於成人及6個月大以上之兒童的主動免疫接種，藉以預防此疫苗所涵蓋之A型與B型流感病毒所引起的流感相關疾病。
|
衛福部核准適用症狀
MOHW approved indications |
預防流感。
|
| 常用劑量 | 立刻使用1vial
(藥品劑量會因人或病情增減，請依照醫師指示服用。) |
| Dose |
1.為單劑0.5mL注射給藥。
2.6個月大以上至未滿9歲且先前未曾接種流感疫苗的兒童，應於間隔至少4週後接種第2劑0.5mL的疫苗。
|
懷孕分級
Pregnancy Risk Factor |
B/C
-
[FDA(美國食品及藥物管理局)懷孕分級說明:
A：對照試驗無法證實懷孕初期及後期使用會危害胎兒。
B：動物試驗無法證實對胎兒有害，但缺乏人類對照試驗；或動物試驗有副作用報告，但無法證實對懷孕初期及後期之胎兒有害。
C：動物實驗中對胎兒有害但缺乏孕婦對照實驗；或無動物及孕婦試驗。
D：證實對胎兒有害，但疾病對孕婦有生命威脅或較安全藥品無法使用或無效時可使用。
X：證實對胎兒有害，且使用後危害大於可能的益處。孕婦及可能懷孕婦女禁用。]
|
| 禁忌症 |
不可用於已知先前曾在施打Fluarix Tetra或流感疫苗後發生嚴重過敏反應或對本疫苗中之任何成分嚴重過敏者。
|
| Contraindications |
Severe allergic reaction (eg, anaphylaxis) to a previous influenza vaccination or to any component of the formulation.
History of severe allergic reaction (eg, anaphylaxis) to egg protein.
|
| 常見副作用 | 腹瀉，肌肉痛，頭痛，疲倦 |
| Common adverse drug reactions | Diarrhea, myalgia, headache, fatigue |
| Adverse Reactions |
Cardiovascular: Chest tightness, hypertension
Central nervous system: Chills, drowsiness, fatigue, headache, irritability, malaise, migraine, shivering
Dermatologic: Diaphoresis, ecchymoses
Gastrointestinal: Abdominal pain, decreased appetite, diarrhea, gastroenteritis, nausea, sore throat, vomiting
Infection: Infection, varicella
Local: Injection site reactions (including bruising, erythema, hematoma at injection site, induration, inflammation, itching at injection site, pain, rash, soreness, swelling at injection site, tenderness at injection site)
Neuromuscular & skeletal: Arthralgia, back pain, myalgia (may start within 6 to 12 hours and last 1 to 2 days; incidence generally equal to placebo in adults; occurs more frequently than placebo in children)
Respiratory: Bronchitis, cough, dyspnea, nasal congestion, nasopharyngitis, oropharyngeal pain, pharyngitis, pharyngolaryngeal pain, rhinitis, rhinorrhea, upper respiratory tract infection, wheezing
Miscellaneous: Fever
|
監測
Monitoring |
Monitor for anaphylaxis and syncope for 15 minutes following administration. If seizure-like activity associated with syncope occurs, maintain patient in supine or Trendelenburg position to reestablish adequate cerebral perfusion.
|
| 警語與注意事項 | 冷藏保存，自費藥，不可口服。 |
| Warnings & precautions | Do not take it orally. Store in the refrigerator. |
| 針劑溶解條件 |
|
| 針劑稀釋條件 |
|
| 針劑不相容性 |
|
| 針劑施打條件 |
僅供肌肉射用。建議於上臂的三角肌處進行注射。
不可注射於臀部或可能有主神經幹通過的部位。
勿以靜脈注射、皮內注射、皮下注射。
|
| 針劑保存安定性 |
2-8°C冷藏避光儲存，請勿冷凍。
|
最近修改日期時間
Updated | 10/29/2020 9:21:34 AM |
|
現用藥品
Available
|
停用藥品
Old item
|
藥品仿單
Package insert sheet
|
|
二維條碼
QR code
|
|